Tumor-Specific Major Histocompatibility-II Expression Predicts Benefit to Anti–PD-1/L1 Therapy in Patients With HER2-Negative Primary Breast CancerPaula I. González-Ericsson, Julia D. Wulfkhule, Rosa I. Gallagher et al.|Clinical Cancer Research|2021Cited by 92
Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast CancerElizabeth C. Wescott, Justin M. Balko, Xiaopeng Sun et al.|Cancer Research Communications|2024Cited by 13
The Impact of <i>JAK1</i> Pathogenic Variants and MHC-I Expression on Response to Immune Checkpoint Inhibition in Endometrial CancerErica V. Carballo, Courtney A. Penn, Paula I. González-Ericsson et al.|Clinical Cancer Research|2025Cited by 2
Figure S2 from Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast CancerElizabeth C. Wescott, Justin M. Balko, Xiaopeng Sun et al.|Unknown|2024Cited by 0
FIGURE 3 from Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast CancerElizabeth C. Wescott, Justin M. Balko, Xiaopeng Sun et al.|Unknown|2024Cited by 0